Design of a phase III multicenter trial to evaluate the efficacy of the RTS,S/AS01 malaria vaccine in children across diverse transmission settings in Africa

@inproceedings{Leach2011DesignOA,
  title={Design of a phase III multicenter trial to evaluate the efficacy of the RTS,S/AS01 malaria vaccine in children across diverse transmission settings in Africa},
  author={Amanda Leach and Johan Vekemans and Marc J. J. Lievens and Opokua Ofori-Anyinam and Conor P. Cahill and Seth Owusu-Agyei and Salim Abdulla and Eus{\'e}bio V Macete and Patricia Njuguna and Barbara M. Savarese and Christian Loucq and William Ripley Ballou},
  booktitle={Malaria Journal},
  year={2011}
}
GlaxoSmithKline Biologicals and the PATH Malaria Vaccine Initiative are working in partnership to develop a malaria vaccine to protect infants and children living in malaria endemic regions of sub-Saharan Africa, which can be delivered through the Expanded Programme on Immunization. The RTS,S/AS candidate vaccine has been evaluated in multiple phase I/II studies and shown to have a favourable safety profile and to be well-tolerated in both adults and children. This paper details the design of… CONTINUE READING
23 Citations
41 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 23 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 41 references

Similar Papers

Loading similar papers…